Page 1245 - Cote clinical veterinary advisor dogs and cats 4th
P. 1245

Mammary Gland Neoplasia, Dog   623


           •  Regular  examination  of  the  mammary    SUGGESTED READING         AUTHOR: Erin K. Malone, DVM, DACVIM
             chain                             De Campos CB, et al. Use of surgery and carboplatin   EDITOR: Kenneth M. Rassnick, DVM, DACVIM
  VetBooks.ir  tion when abnormalities are found  with advanced clinical staging. In Vivo 28:863-866,                 Diseases and   Disorders
           •  Prompt presentation for veterinary examina-
                                                in feline malignant mammary gland neoplasms
                                                2014.





            Mammary Gland Neoplasia, Dog                                                           Client Education
                                                                                                          Sheet


            BASIC INFORMATION                   ○   TP53                            ○   Regional lymph node: N0, no metastasis;
                                                ○   ERBB2 (HER2/NEU)                  N1, metastasis detected
           Definition                           ○   BCRA1, BCRA2                    ○   Distant  metastasis:  M0,  no  metastasis;
           Mammary gland tumors are benign or malig-                                  M1, metastasis detected
           nant neoplasms arising from mammary tissue.  RISK FACTORS
                                               •  Timing of OHE affects the relative risk of
           Synonyms                             developing mammary gland tumors.
           •  Mammary or breast cancer/tumor    ○   0.5% of the risk of an intact bitch if OHE   Stage Grouping  T  N  M
           •  Benign  mammary  tumors:  adenoma/  is performed before the first estrus
             cystadenoma, benign mixed mammary   ○   8% of the risk of an intact bitch if OHE   I  T1   N0     M0
             tumor, duct papilloma, myoepithelioma,   is performed between the first and second   II  T2  N0   M0
             complex adenoma, fibroadenoma        estrus                           III            T3    N0     M0
           •  Malignant mammary tumors: carcinoma in   ○   26% of the risk of an intact bitch if OHE   IV  T1-3  N1  M0
             situ, simple carcinoma (tubular/tubulopapillary,   is performed between the second and third
             solid, cribriform, and anaplastic), complex car-  estrus              V              T1-3  N0, N1  M1
             cinoma, inflammatory carcinoma (uncommon),   •  Females  spayed  after  2  years  of  age  have
             carcinosarcoma (rare), sarcomas (fibrosarcoma,   a sevenfold greater risk of mammary
             osteosarcoma, other; uncommon)     neoplasia than those spayed before age
           •  Different pathologic classification schemes   6 months.             •  Histologic staging
             exist.                            •  Body condition/diet: reduced risk (odds ratio   ○   0: carcinoma in situ
                                                = 0.04) in dogs with lean body condition at   ○   1: stromal invasion
           Epidemiology                         age 9-12 months                     ○   2:  vascular/lymphatic  invasion;  lymph
           SPECIES, AGE, SEX                   •  Hormone  therapy:  progesterone  and/or   node metastasis
           •  Mammary gland tumors are common tumors   estrogen administration may lead to a greater   ○   3: distant metastases
             in female dogs, and the most common tumor   than twofold increase in the risk of benign   •  Histologic grading of carcinomas is based
             in intact female dogs.             and malignant mammary tumors.       on tubule formation, nuclear pleomorphism,
             ○   Incidence ≈2:1000             •  Pregnancy, lactation, pseudocyesis  and mitotic  index  and offers  prognostic
             ○   Due to the common practice of early-age   ○   Unlike in people, pregnancy does not   significance. Low-, intermediate-, and high-
               ovariohysterectomy (OHE), the incidence   afford a protective effect against the   grade tumors correspond to well, moderately,
               has  decreased  in  the  United  States.  In   development of mammary tumors in dogs.   and poorly differentiated tumors.
               European  countries,  mammary  tumors   Lactation and pseudocyesis also do not
               represent  40%-70%  of  all  tumors  in   seem to have an influence.  HISTORY, CHIEF COMPLAINT
               female dogs.                                                       •  Owners  may  notice  a  swelling,  lump,  or
           •  Mammary tumors affect middle-aged to older   ASSOCIATED DISORDERS     ulceration  in their dog’s mammary chain,
             dogs; median age for malignant tumors is   •  Ovarian cysts, cystic endometrial hyperplasia  or it may be an incidental finding on routine
             10-11 years.                      •  Mammary  tumors  in  male  dogs  may  be   physical exam.
           •  Mammary gland tumors in male dogs are   associated with hormonal disturbances (e.g.,   •  Duration of clinical signs is highly variable,
             uncommon (≈1% of mammary tumors occur   estrogen-secreting testicular Sertoli cell tumor).  ranging from days to months.
             in males).                        •  Up  to  21%  of  dogs  with  inflammatory   •  With metastasis or inflammatory carcinoma,
                                                carcinoma may have concurrent disseminated   dogs may be presented due to general signs
           GENETICS, BREED PREDISPOSITION       intravascular coagulation (DIC), and appro-  of illness or specific complaints attributable
           •  Breeds at increased risk          priate testing should be assessed accordingly   to a certain site of metastasis (e.g., lameness
             ○   Spaniel breeds                 (p. 269).                           in cases of bone metastasis, cough due to
             ○   Pointer breeds                •  Secondary  inflammatory  carcinoma  may   pulmonary metastasis).
             ○   Poodles                        develop after (mean, 48 days) surgical removal
             ○   Dachshunds                     of a mammary tumor; secondary inflamma-  PHYSICAL EXAM FINDINGS
             ○   German shepherds               tory carcinoma typically behaves as aggressively   •  Varies, depending on extent and stage of the
             ○   Yorkshire terriers             as primary inflammatory carcinoma.  disease
           •  There  seems  to  be  a  genetic  factor  in  the   Clinical Presentation  •  Single or multiple nodules may be present.
             development of mammary tumors, but a                                   Multiple tumors are common in dogs, and
             specific, common mutation has not been   DISEASE FORMS/SUBTYPES        both mammary chains may be affected. The
             identified. The following genes have been   •  Clinical staging        caudal glands are affected most frequently.
             found  to  be  mutated  in  selected  canine   ○   Tumor: T1  <  3  cm; T2  3-5  cm; T3  >    Multiple tumor types among different glands
             mammary gland tumors (p. 621):       5 cm                              are common.

                                                      www.ExpertConsult.com
   1240   1241   1242   1243   1244   1245   1246   1247   1248   1249   1250